Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03772405Completed
Randomised, open-label trial, sponsored by Fraunhofer ITEM. Primary endpoint: Total Nasal Symptom Score. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03772405.